Cargando…
The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-elevation myocardial infarction: a brief communication
BACKGROUND: The expression of pregnancy-associated plasma protein A (PAPP-A) was identified by immunohistochemistry (IHC) in culprit atherothrombotic plaque specimens harvested from patients admitted with ST-segment elevation myocardial infarction (STEMI). METHODS: The atherothrombotic samples were...
Autores principales: | Brügger-Andersen, Trygve, Bostad, Leif, Sandnes, Dagny Ann, Larsen, Alf Inge, Bonarjee, Vernon VS, Barvik, Ståle, Melberg, Tor, Nilsen, Dennis WT |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837619/ https://www.ncbi.nlm.nih.gov/pubmed/20181026 http://dx.doi.org/10.1186/1477-9560-8-1 |
Ejemplares similares
-
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease
por: Nilsen, Dennis W. T., et al.
Publicado: (2022) -
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
por: Bonarjee, Vernon VS, et al.
Publicado: (2001) -
Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease
por: Olie, Renske H., et al.
Publicado: (2019) -
Arterial Stiffness: A Prognostic Marker in Coronary Heart Disease. Available Methods and Clinical Application
por: Bonarjee, Vernon V. S.
Publicado: (2018) -
Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)